BioMarin

In News

Here Is Why BioMarin (BMRN) Is Projected to Rally - MSN

MSN - Apr 15, 2026

BioMarin Pharmaceutical's Rare Disease Portfolio Supplemented By Amicus Acquisition Makes A Buy - Seeking Alpha

Seeking Alpha - Apr 15, 2026

Is BioMarin Pharmaceutical (BMRN) Now Attractive After Prolonged Share Price Weakness? - Yahoo Finance

Yahoo Finance - Apr 12, 2026

An Open Letter to the Pompe and Fabry Communities - BioMarin Pharmaceutical

BioMarin Pharmaceutical - Mar 27, 2026

BioMarin pumps brakes on 3 Voxzogo studies as competition in drug's flagship achondroplasia indication mounts - Fierce Pharma

Fierce Pharma - Mar 16, 2026

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update - PR Newswire

PR Newswire - Oct 27, 2025

Paragon Capital Invests $1.19M in BioMarin Pharmaceutical - National Today

National Today - Apr 13, 2026

What BioMarin Pharmaceutical (BMRN)'s Voxzogo Trial Stops and Mixed Safety Data Mean For Shareholders - simplywall.st

simplywall.st - Mar 31, 2026

BioMarin stops mid-stage trials of bone disorder treatment - Reuters

Reuters - Mar 16, 2026

BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results - PR Newswire

PR Newswire - Feb 23, 2026

Chieze Ibeneche-Nnewihe Reflects on Her Journey from Amateur Scientist to Business Development Leader - BioMarin Pharmaceutical

BioMarin Pharmaceutical - Feb 18, 2026

Is It Time To Reassess BioMarin Pharmaceutical (BMRN) After A 42.7% Three-Year Share Price Fall - simplywall.st

simplywall.st - Apr 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment